Junshi Biosciences Announces Toripalimab in Combination : vimarsana.com

SHANGHAI, China, Feb. 20, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced...

Related Keywords

China , Guangzhou , Guangdong , Shanghai , United States , Uzbekistan , Suzhou , Jiangsu , Beijing , Jianjun , Shaanxi , Maryland , San Francisco , California , Chinese , Junshi Bioscience , Junshi Biosciences , Zhi Li , Global Research , Ir Team , Drug Administration , Data Monitoring Committee , National Reimbursement Drug List , European Medicines Agency , Pr Team , Chinese People Liberation Army , Healthcare Products Regulatory Agency , Chinese Society Of Clinical Oncology , Department Of Oncology , Shanghai Junshi Biosciences Co Ltd , Independent Data Monitoring Committee , Professor Zefei , Chinese People , Liberation Army General Hospital , Vice President , Secretary General , Chinese Society , Clinical Oncology , Principal Investigator , Southeast Asia , Biologics License Application , Chinese Academy , Emergency Use Authorizations , Hong Kong Stock Exchange 1877 Hk , Unshi Biosciences ,